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Abstract 
Pancreas specific transcription factor 1a (Ptf1a), a bHLH transcription factor, has two 
temporally distinct functions during pancreas development; initially it is required for early 
specification of the entire pancreas, while later it is required for proper differentiation 
and maintenance of only acinar cells. The importance of Ptf1a function was revealed by 
the fact that loss of Ptf1a leads to pancreas agenesis in humans. While Ptf1a is one of 
the most important pancreatic transcription factors, little is known about the differences 
between the regulatory networks it controls during initial specification of the pancreas as 
opposed to acinar cell development, and to date no comprehensive analysis of its 
downstream targets has been published. In this paper, we use Xenopus embryos to 
identify putative downstream targets of Ptf1a. We isolated anterior endoderm tissue 
overexpressing Ptf1a at two early stages, NF32 and NF36, and compared their gene 
expression profiles using microarrays. Our results revealed that Ptf1a regulates genes 
with a wide variety of functions, providing insight into the complexity of the regulatory 
network required for pancreas specification.  
 
Introduction 
The pancreas is an endodermal organ comprised of exocrine and endocrine cells. 
Exocrine tissue includes acinar cells that secrete digestive enzymes and ductal cells 
that transport the enzymes to the duodenum. Endocrine tissue is composed of five cells 
types, α, β, δ, ε and PP, which secrete glucagon, insulin, somatostatin, ghrelin and 
pancreatic polypeptide hormones, respectively, into the bloodstream. 
The embryological origin of the pancreas is conserved from mammals to amphibians, 
where the pancreas develops from separate dorsal and ventral buds (Gittes, 2009; Kelly 
and Melton, 2000; Pearl et al., 2009). In Xenopus laevis, the dorsal bud arises first at 
NF35/36 just below the notochord at the level of the pronepheros. The ventral pancreas 
derives from two anlagen at the junction of the liver bud and developing duodenum at 
NF37/38. Morphological movements of the gastrointestinal tract during NF39 and 40 
lead to the repositioning of the pancreatic buds driving their fusion and the formation of 
a single discrete organ (Jarikji et al., 2009; Kelly and Melton, 2000; Pearl et al., 2009). 
Prior to the emergence of the dorsal pancreatic bud, punctate expression of the beta 
cell differentiation marker insulin is detectable by in situ hybridization as early as NF32; 
subsequent expression within the ventral pancreas does not occur until NF47 (Horb and 
Slack, 2002; Kelly and Melton, 2000). Unlike insulin, expression of the other two 
endocrine markers, glucagon and somatostatin, are not restricted to the pancreas. 
These two genes are initially expressed in a punctate pattern within the stomach and 
duodenum at NF41, and are only detected in the pancreas beginning at NF44/45. The 
rapidity of pancreas development in Xenopus, coupled with its embryological and 
molecular benefits, makes it a useful system for functional studies on pancreas 
development (Blitz et al., 2006; Harland and Grainger, 2011; Pearl et al., 2012).  
In the last few years our lab has utilized these benefits to characterize the function of 
several new genes in Xenopus pancreas development. First, in studying liver to 
pancreas transdifferentiation we found that Ptf1a and Pdx1 were sufficient to convert 
liver to pancreas in Xenopus transgenics (Horb et al., 2003; Jarikji et al., 2007). Second, 
we isolated individual dorsal and ventral pancreatic buds prior to fusion and used 
microarrays to compare their gene expression profiles. From this we characterized the 
function of three different genes, Insm1 (zinc finger transcription factor), Tm4sf3 
(tetraspanin) and Brunol1 (RNA binding protein) and showed that they were involved in 
endocrine cell differentiation, fusion of the pancreatic buds and proliferation of 
endodermal progenitor cells, respectively (Horb and Horb, 2010; Horb et al., 2009; 
Jarikji et al., 2009). Third, we showed that Staufen2, an RNA binding protein, played an 
essential role in early patterning of the anterior endoderm (Bilogan and Horb, 2012). 
Fourth, we performed an exhaustive functional analysis of Rfx6, a neonatal diabetes 
candidate gene, and through microarray analysis identified new target genes involved in 
development of several anterior endodermal organs (Pearl et al., 2011). Fifth, we 
recently described a novel protocol to maximize production of pancreatic beta cells over 
alpha cells by controlled overexpression of the pancreatic endocrine transcription factor 
Ngn3 in naïve endoderm; using this gain-of-function phenotype we isolated endoderm 
shortly after Ngn3 expression and identified novel downstream targets that function 
downstream of Ngn3 (Oropez and Horb, 2012). These studies demonstrate the benefits 
of using Xenopus to study pancreas development, namely the ability to perform both 
gain and loss-of-function studies in naïve endoderm and the ability to make transgenics 
rapidly for tissue specific overexpression studies. In this paper we describe a combined 
gain-of-function approach with microarray analysis to identify new target genes of a 
pancreatic transcription factor (Ptf1a) in Xenopus endoderm. 
 
The basic helix-loop-helix (bHLH) protein Ptf1a (pancreas specific transcription factor 
1a) is one of the first endodermal transcription factors restricted to early pancreatic 
progenitors before overt morphogenesis of the dorsal and ventral buds (Kawaguchi et 
al., 2002). Ptf1a has different stage-specific functions that are crucial for proper 
pancreas organogenesis. Initially, it is required to specify undifferentiated foregut 
endoderm into a pancreatic fate (Kawaguchi et al., 2002). Later, its expression becomes 
restricted to the cells at the tip of the pancreas where it functions in the initiation and 
maintenance of acinar cells (Krapp et al., 1996; Masui et al., 2007). The different 
functions are largely dependent on protein binding partners of Ptf1a, specifically which 
RBPJ paralog is bound by Ptf1a. RBPJ, the vertebrate Suppresor of Hairless [Su(H)], is 
found in the early PTF1 complex (PTF-J) and is required for the epithelial growth and 
development of the dorsal and ventral pancreatic buds.  The PTF1-J complex binds to 
the Rbpjl promoter, activates its expression, and is eventually replaced by the RBPJL in 
the PTF1 complex (PTF1-L) during acinar cell differentiation (Masui et al., 2007). The 
PTF1-L complex then activates the promoters of genes encoding the secretory digestive 
enzymes (Beres et al., 2006). In humans, loss-of-function gene mutations in PTF1A 
lead to pancreatic and cerebellar agenesis (Sellick et al., 2004). Similarly loss-of-
function studies in mice and zebrafish revealed that functional Ptf1a is essential for 
exocrine cell development and the development of a subset of endocrine cells 
(Kawaguchi et al., 2002; Krapp et al., 1998; Lin et al., 2004; Zecchin et al., 2004).  
In Xenopus, we found Ptf1a to be both necessary and sufficient for development of the 
pancreas. Morpholino knockdown of Ptf1a resulted in a complete loss of exocrine cells 
and loss of a subset of endocrine cells, while overexpression of Ptf1a was found 
sufficient to promote ectopic development of pancreatic cells (Afelik et al., 2006; Jarikji 
et al., 2007).  Overexpression of ptf1a mRNA in naïve endoderm was sufficient to 
respecify early stomach and duodenal cells into both acinar and endocrine pancreas 
cells, while a superactive version was only capable of promoting an acinar cell fate. 
Similarly, we showed that transgenic overexpression of Ptf1a at later stages (after the 
foregut organs had formed) was able to promote ectopic endocrine and exocrine cell 
fates within the stomach and duodenum. Though we know Ptf1a can specify both 
endocrine and exocrine cell fates, the transcriptional hierarchy downstream of Ptf1a is 
still unknown. 
In an attempt to elucidate the gene regulatory network activated by Ptf1a in early 
pancreas development we set out to identify gene expression changes that occurred 
upon overexpression of Ptf1a at the onset of pancreas development. Taking advantage 
of the Ptf1a overexpression phenotype, we compared control endodermal tissue to 
Ptf1a overexpression tissue at two early time-points, NF32 and NF36. This led to the 
identification of many genes with altered expression levels; the genes identified had 
varied functions revealing the diverse roles of Ptf1a in early pancreas development. We 
describe the expression of seven candidate genes with functions ranging from 
transcription, vesicle fusion and cell adhesion.  In addition, we identified novel genes 
expressed within the developing pancreatic endoderm.  
Results 
Microarray analysis endodermal tissue overexpressing Ptf1a 
We previously showed that overexpression of Pf1a was sufficient to convert stomach 
and duodenum to pancreas (Jarikji et al., 2007). Based on this phenotype we sought to 
identify downstream targets of Ptf1a by isolating endodermal tissue overexpressing 
Ptf1a at two early time-points and comparing the gene expression changes using 
microarrays. The first microarray was performed at NF32, which is shortly after 
endogenous Ptf1a expression begins (named MA32); the second microarray was 
performed at NF36 (MA36), which is 8 hours after the first time-point.  
We injected ptf1a and gfp mRNAs together or gfp mRNA alone into the two dorso-
vegetal blastomeres of eight-cell embryos, targeting the anterior endoderm. Forty 
(NF32) to forty-eight (NF36) hours later the anterior endoderm was dissected out and 
total RNA isolated. 15 endoderm explants were pooled for each RNA preparation, and 
both control and experimental samples were collected from the same clutch of embryos. 
This was done in triplicate at NF32 and in quadruplicate at NF36, each replicate coming 
from sibling embryos (Fig. 1a). The NF36 microarray was performed first using the 
Affymetrix 3’ Xenopus laevis Genome 1.0 GeneChip, and the NF32 microarray second 
using the Affymetrix 3’ Xenopus laevis Genome 2.0 GeneChip (the NF36 microarray 
was performed prior to the release of the 2.0 GeneChip). Primary analysis was done 
using the Affymetrix algorithm PLIER and globally normalized to 100% of the mean 
value. Multiple t-tests were used, including a Cyber-T test, a probability interval of 0.9 
and 0.95 was set and only genes with a minimal fold change of 2.0 were identified as 
candidate genes. The analysis yielded 296 probe sets up-regulated at NF32 and 846 
probe sets up-regulated at NF36.  
In agreement with our previous data that showed Ptf1a was sufficient to promote 
ectopic acinar cell development (Jarikji et al., 2007), we found up-regulated expression 
of numerous exocrine genes in endodermal tissue overexpressing Ptf1a at both time-
points. Carboxypeptidase A (CPA) was up-regulated 4-fold in both MA32 and MA36 
(Table 1) and Carboxypeptidase B1 (CPB1) was up-regulated 6-fold in MA36 (Table 3). 
Endocrine genes were also found up-regulated, including Pax6, NeuroD, 
Carboxypeptidase E (CPE) and Somatostatin. Pax6 and CPE were found upregulated 
2.7-fold and 2.46-fold in MA32 (Table 2). NeuroD and somatostatin were found 
upregulated 5-fold and 4.33-fold in MA36 (Fig. 1b,c, Table 3). In conjunction with our 
previous results that showed loss of stomach and duodenal tissue, we found down-
regulated expression of several stomach and duodenal genes, such as villin-1 and 
intestinal fatty acid binding protein (IFABP) in endoderm overexpressing Ptf1a (data not 
shown, see GEO data GSE34193). In summary, we found the changes in gene 
expression identified in the microarrays were consistent with our earlier data, 
suggesting genes identified in the microarray are involved in promoting the ectopic 
pancreas phenotype. 
 
Identification of temporally regulated genes. 
To compare differential gene up-regulation in the two different time-points, we 
separated the genes based on whether they were up-regulated in both MA32 and MA36 
or only in one time-point. Using MA32 as the base we identified 297 genes to be up-
regulated greater than 2-fold in both MA32 and MA36 (Table 1). At NF32, we identified 
143 genes to be up-regulated only at this stage, while at NF36 there were 702 up-
regulated genes (Tables 2 & 3). Due to the extended amount of time between onset of 
endogenous Ptf1a expression and sample collection, we believe those genes up-
regulated at the later stage represent secondary or tertiary targets of Ptf1a and not 
direct targets. 
To provide insight into the different genes regulating pancreas specification downstream 
of Ptf1a at NF32 versus NF36, we used DAVID (Database for Annotation, Visualization 
and Integrated Discovery) to map the up-regulated genes from both microarrays to 
enriched GO Biological Process categories (Huang da et al., 2009a; Huang da et al., 
2009b). Gene annotation enrichment analysis revealed the top three functions at MA32 
were regulation of transcription, regulation of RNA metabolic process and biological 
adhesion. At this stage there appears to be enrichment of genes that may function in 
cell fate specification and in cell biological processes, such as adhesion for tissue 
patterning. In comparison, at MA36 the top three functions were ion transport, nitrogen 
compound biosynthetic process and purine nucleotide metabolic process. As expected, 
genes at this later stage appear to be enriched in functions indicative of differentiated 
cells in comparison to naïve cells undergoing specification. 
Temporally regulated genes were also mapped using SwissProt to determine enriched 
functions. The top 3 enhanced keywords at MA32 were developmental proteins, calcium 
and intermediate filaments. At MA36, the top 3 enhanced functional similarities were 
transmembrane related proteins, calcium and intermediate filaments. The enrichment of 
developmental proteins at MA32 suggested Ptf1a was regulating the expression of 
genes required to define the pancreatic fate at this early stage. At MA36, the most 
enriched protein family was transmembrane related proteins, which included many 
proteins with functions in signal transduction pathways (e.g., guanylyl cyclase 1, EPH 
receptor B1, Syndecan-4). The difference between the enriched protein families across 
the time-points correlates with our analysis that up-regulated genes at NF32 are 
functioning in cell fate specification, while at NF36 the cells are more differentiated and 
these putative secondary or tertiary Ptf1a target genes are involved in maintaining 
proper cell function. 
Analysis of the 1142 probe sets up-regulated in both microarrays showed the most 
enriched GO Biological Process category was transcriptional regulation. Of the 45 
transcription factors that were up-regulated, we identified known pancreatic transcription 
factors that function downstream of Ptf1a (NeuroD1, Pax6, Sox9), which have been 
shown to be expressed in the pancreas at these two stages. We also identified many 
genes with known functions in pancreas development that have yet to be identified as 
Ptf1a targets (JunB, IRF1, Hey1). However, the majority of up-regulated genes have 
unknown functions in pancreas development (Sox3, Hairy2, FoxC1), though related 
family members have been shown to play a role in pancreas development. The 
identification of both known and unknown pancreatic genes suggested that these new 
transcription factors might be part of the initial Ptf1a gene regulatory network. However, 
further functional analysis is required to validate and understand the roles of these 
potential pancreatic transcription factors. 
 
Genes up-regulated in Ptf1a microarray are expressed during early pancreas 
specification 
To validate genes involved in early pancreatic specification from the up-regulated probe 
sets, we chose to examine the spatial and temporal expression of 94 genes by whole-
mount in situ hybridization (ISH). We confirmed 50 of these genes to be expressed in 
anterior endoderm, but we focused our attention on the 32 that showed specific 
expression within the mature pancreas (between NF40 and NF46). Of the 32 genes 
expressed in the mature pancreas, 9 genes showed expression within the anterior 
endoderm at the level of the developing pancreas between NF32-36. The 9 
endodermally expressed genes were: syntaxin binding protein 1 (Stxbp1), putative 
transmembrane protein TA-2, cholesterol 25-hydroxylase (C25H), Insulin-like growth 
factor binding protein 1 (Igfbp1), interferon regulatory factor 1 (Irf1), hyaluronan and 
proteoglycan link protein 3 (Hapln3), hairy/enhancer-of-split related with YRPW motif 1 
(Hey1), sestrin1, syndecan-4.  
According to the microarray analysis six of the genes, TA-2, C25H, Irf1, Hapln3, Hey1 
and Syndecan-4, were found significantly up-regulated at both NF32 and NF36; Igfbp1 
and Sestrin1 were only up-regulated at NF36, whereas Stxbp1 was only up-regulated at 
NF32. Consistent with the microarray data, we confirmed relative expression for seven 
of these genes by RT-PCR (Fig. 2). However, we found expression of C25H and TA-2 
to be reduced in the Ptf1a samples at MA36 (Fig. 2). As a control, we examined 
expression changes for one of the genes found decreased in both MA32 and MA36, 
cellular retinol binding protein 2 (Crbp2). In agreement with the microarray data, we 
found it to be decreased in Ptf1a overexpressing endoderm (Fig. 2). These results 
suggested that genes identified in the analysis were targets of Ptf1a, and based on the 
confirmation of the RT-PCR and their known functions and putative roles in pancreas 
development, we examined seven genes in more detail, Hey1, Irf1, Stxbp1, Syntaxin 
1B, Igfbp1, Hapln3 and Syndecan-4. 
 Hey1 
Hey1 is a bHLH transcriptional repressor protein that was shown to interact with Ptf1a 
and is expressed in both endocrine and exocrine cells of the human pancreas (Ghosh 
and Leach, 2006; Johansson et al., 2008). In Xenopus embryos, we first detected hey1 
expression at NF32 along the periphery of the endoderm (Fig. 3a,b). At later stages 
expression becomes restricted to the stomach and pancreas (Fig. 3c). To confirm the 
RT-PCR data we compared the spatial expression of hey1 in control and ptf1a-injected 
embryos. At NF32, expression of hey1 in ptf1a-injected embryos was stronger 
particularly in the ventral and dorsal region of the endoderm where the pancreatic buds 
will arise (Fig. 6a,b). At NF36, expression of hey1 remained much stronger in the 
endoderm in comparison to the controls (Fig. 6c,d). Expression of hey1 in the 
developing endoderm and up-regulation in the region of the prospective pancreatic buds 
suggests it is a downstream target of Ptf1a in vivo and likely plays a role in pancreatic 
cell specification. 
 Irf1 
Irf1 was originally identified as a regulator of interferon (IFN)-β and is a key factor in the 
transcriptional regulation of the IFN response, but it has also been studied for its role in 
cell growth regulation (Fujita et al., 1988; Kröger et al., 2002). In the domain of the 
developing pancreas in Xenopus at NF32, irf1 was expressed along the ventrolateral 
endoderm; this expression expanded laterally by NF36 (Fig. 3d,e). Within the mature 
gut, the expression was dispersed throughout the duodenum and liver (Fig. 3f). The 
developing anterior endoderm not only gives rise to the pancreas, but also the liver, 
stomach and intestine. Since overexpression of Ptf1a is sufficient to convert stomach 
and duodenum to pancreas it is possible that Ptf1a may activate genes, such as Irf1, 
that inhibit proper stomach and duodenum development.   
 Stxbp1 
In our microarray, we also identified several proteins involved in vesicle fusion. As 
examples, we focused our analysis on Stxbp1 and Syntaxin 1B, as they were both up-
regulated over two-fold. Stxbp1 was originally identified for it role in exocytosis through 
yeast genetics as Sec1 (Ferro-Novick and Jahn, 1994). Homologs have been identified 
in many species from Caenorhabditis elegans (UNC-18) to mammals (Munc-18) (Hata 
et al., 1993; Hosono et al., 1992). Stxbp1 is known to function in neuronal cells as well 
as in pancreatic islets and insulin-producing cells (Jacobsson et al., 1994). In Xenopus 
embryos, stxbp1 was expressed within the dorsal mesendoderm border at NF32 (Fig. 
4a), by NF36 it was expressed in a punctate fashion within the dorsal endoderm at the 
level of the developing pancreatic bud (Fig. 4b). In the mature gut, stxbp1 expression 
was punctate throughout the stomach, duodenum and pancreas (Fig. 4c,d). These 
results indicate that stxbp1 was expressed in a punctate pattern in the developing 
dorsal pancreatic bud, similar to the expression of insulin in the dorsal anlagen prior to 
pancreas morphogenesis. 
 Syntaxin 1B 
Syntaxin 1B is a member of the t-SNARE family, these proteins are located in the 
plasma membrane and play a fundamental role in vesicle docking and fusion (Ferro-
Novick and Jahn, 1994). Stxbp1 can directly bind Syntaxin, this interaction has been 
shown to result in negative regulation of the insulin secretory machinery in insulin-
secreting HIT-T15 cells (Hata et al., 1993; Zhang et al., 2000). In Xenopus embryos 
syntaxin 1B was not expressed within the developing pancreatic buds (Fig. 4e,f), but it 
was uniformly expressed through the mature stomach, liver and pancreas (Fig. 4g,h). At 
both NF32 and 36 in ptf1a-injected embryos, syntaxin 1B expression was ectopically 
expressed in the dorsal and ventral endoderm (Fig. 6e-h). At this early stage insulin 
mRNA is only beginning to be expressed, and it is unclear what role these genes, which 
are implicated in insulin-release, might play at such an early stage in development. 
 Igfbp1 
Insulin-like growth factor-binding proteins (IGFBPs) are secreted proteins that bind to 
Insulin-like growth factors (IGFs) and sequester them from binding to the IGF receptor, 
which plays a crucial role developmental growth and metabolism (Duan, 2002; Hwa et 
al., 1999). In confirmation of the microarray, we found igfbp1 to be expressed within the 
developing endoderm at all stages examined. At NF32 it was expressed in the ventral 
endoderm and dorsolateral mesoderm (Fig. 5a). Eight hours later at NF36 expression 
within the endoderm increased, and was now found to extend into the dorsal endoderm 
(Fig. 5b). In isolated guts at NF45, expression was strongest in the liver, but was also 
found diffuse throughout the posterior part of the gut (Fig. 5c). In ptf1a overexpressed 
embryos expression was expanded in the ventral endoderm at NF32 (Fig. 6m,n). 
Similarly at NF36 igfbp1 expression was stronger in the ventral endoderm in 
comparison to the control and the punctate pattern was more abundant (Fig. 6o,p). 
Concentrated igfbp1 expression in the ventral endoderm was amplified in ptf1a-injected 
embryos, and based on these observations we consider that it may play a role specific 
for only ventral pancreas development. 
 Hapln3 
Hyaluronan and proteoglycan-binding link protein 3 (Hapln3) is a member of the link-
protein family HAPLN, in Xenopus Hapln3 was identified as an essential extracellular 
matrix protein that stabilizes hyaluronan matrix formation during cardiogenesis (Ito et 
al., 2008). Our analysis of halpn3 expression showed it to be highly expressed within 
the most ventral endoderm at NF32 (Fig. 5d). At later stages, halpn3 expression was 
barely detectable in the endoderm (Fig. 5e,f). In embryos overexpressing ptf1a mRNA, 
hapln3 was expressed in broader and stronger pattern in the ventral endoderm at NF32 
(Fig. 6i,j). At NF36, ectopic expression of hapln3 was observed in the ventral endoderm 
in ptf1a-injected embryos (Fig. 6k,l). These results indicate that hapln3 is expressed in 
the ventral endoderm prior to morphogenesis of the pancreatic buds, and this ventral 
expression was up-regulated in embryos overexpressing ptf1a mRNA in the developing 
anterior endoderm. 
 Syndecan-4 
Lastly, we focused on Syndecan-4, which as a member of the Syndecan family is a 
heparan sulfate bearing transmembrane protein involved in cell adhesion and linkage to 
the cytoskeleton (Whiteford et al., 2008). At NF32 faint syndecan-4 expression was 
detected in the ventral endoderm (Fig. 5g). By NF36, expression within the most ventral 
portion of the endoderm was increased substantially (Fig. 5h). In NF44 guts syndecan-4 
was most strongly expressed within the stomach, but expression was also detected in 
the liver (Fig. 5i). These observations indicate that syndecan-4 is expressed in the 
ventral endoderm during stages when the ventral pancreatic cells are being specified. 
 
 
Discussion 
Numerous studies have addressed the transcription factor hierarchy involved in 
pancreas development. Ptf1a is a particularly interesting gene in this cascade, as it is 
one of the earliest transcription factors to have restricted expression within the 
developing pancreatic buds. Ptf1a plays two roles, early in initial pancreas specification 
and later in maintenance of mature pancreatic exocrine cells. While a greater 
understanding of its function in exocrine cell maintenance has been achieved, much 
less is known about the genes activated downstream of Ptf1a during initial stages of 
pancreas development. In this paper we have used mRNA overexpression and 
microarray analysis to identify early downstream targets of Ptf1a that may play a role in 
initial specification of the pancreas. From this study, we identified numerous genes that 
were not previous known to function in pancreas development 
Through microanalysis of Ptf1a overexpression over two time-points we have identified 
over 800 genes that are temporally regulated within the anterior endoderm during the 
initial stages of pancreas development, and have validated a subset of these which 
show expression within the anterior endoderm. Many of these have no prior known 
function in pancreas development. A total of 45 transcription factors were identified in 
our analysis, and while the majority of these have no known role in pancreas 
development, several established regulators of pancreas development were observed 
(NeuroD1, Atf3, Sox9).  This suggests the other up-regulated transcription factors in our 
data sets are likely to also play a role in pancreas development.  
Using gene annotation enrichment analysis we have identified differences between the 
two time-points. At NF32 the most enhanced gene sets are involved in transcriptional 
regulation, biological adhesion and have known functions during development. This 
suggests that Ptf1a directly activates genes involved specification of the pancreatic cells 
and developing tissue. Genes up-regulated at NF36 are likely secondary or tertiary 
targets of Ptf1a, and at this stage the pancreas has formed into buds that will soon fuse 
to form a discrete organ. From this data set, we identified many genes enriched in 
transmembrane function and ion transport. 
Although Ptf1a has been shown to be essential for development of a subset of 
endocrine cells, little is know about how it specifies these cells. To begin to define the 
Ptf1a endocrine regulatory circuit we sought to identify overlap between the Ptf1a and 
endocrine Ngn3 regulatory network, which we recently published (Oropez and Horb, 
2012). This analysis identifed a list of 14 genes potentially involved in endocrine cell 
development (Data not shown). Five of the identified genes have previous known 
pancreatic function (CPE, Hey1, Hes5, Ptgs2, NeuroD4). The identification of all these 
genes in both the Ngn3 and Ptf1a microarrays strongly suggest they function 
downstream of these key transcription factors in early pancreas specification, but 
exactly what role they might play in early pancreas specification downstream of Ptf1a is 
not known. However, this overlap provides a starting point for further evaluation of these 
genes to define the overlap between the Ptf1a and Ngn3 pathways. 
 
Endodermally expressed candidate genes 
The specification of pancreatic cell lineages involves sequential activation of several 
classes of transcription factors, in this study we identified two transcription factors 
expressed within the developing endoderm and up-regulated by Ptf1a: Irf1 and Hey-1. 
Irf1 has been studied for its involvement in immune response, including islet 
inflammation, but has other known roles in tumor suppression, apoptosis and cell 
growth regulation (Fujita et al., 1988; Kröger et al., 2002). Irf1 was up-regulated 3-fold at 
NF32 and 7-fold at NF36, and given its previous known functions it is possible the role 
of Irf1 downstream of Ptf1a may be to inhibit growth of naïve duodenal cells into a 
mature organ. 
Early in pancreas development the Notch signaling pathway regulates cell fate 
differentiation. Ultimately it activates target genes, including the Hairy Enhancer of Split 
(HES) family of bHLH transcriptional repressors, which maintain cells in an 
undifferentiated state. Later in development Notch has been shown to delay the onset of 
the exocrine lineage; effector proteins of Notch, including Hes1, Hey1 and Hey2 are 
capable of interacting with Ptf1a and preventing the PTF1 complex from binding to 
target DNA (Esni et al., 2004; Ghosh and Leach, 2006). It is likely that Hey1 is 
interacting with Ptf1a to maintain pancreas progenitor cells in an undifferentiated state 
leading to an increase in cell growth and pancreatic cells. 
We also identified genes with known functions in mature pancreatic cells, such as 
Stxbp1 and Igfbp1, but their role in pancreas development has not yet been studied. In 
mice there are three Munc18 (the mammalian stxbp1 homolog) isoforms: Mucn18a, 
Munc18b and Munc18c, all of which are expressed in islet β-cells and function in insulin 
release (Oh and Thurmond, 2009; Spurlin et al., 2004; Tomas et al., 2008). These 
cytosolic proteins are also capable of binding to Syntaxin with high affinity, and this 
interaction is known to have both inhibitory and positive roles in vesicle transport 
(Lehtonen et al., 1999). Not only is binding partner Syntaxin 1B up-regulated in the 
microarrays, but so are many other components of the SNARE complex, such as 
SNAP-25, Synaptotagmin-like 1, Synaptotagmin 4, Synaptophysin A and B and VAMP-
2. At this early stage in pancreas development at which our microarrays are performed 
insulin is not yet being released, suggesting that Stxbp1 and components of the SNARE 
complex may have other functions early during pancreas development, such as 
generation of polarization of specific cells leading to a differentiated cell fate (Lehtonen 
et al., 1999). 
Igfbp1 has been shown to function independently of IGF, it can inhibit the mitogenic 
activity of epidermal growth factor (EGF) when bound to certain integrins and it also 
enhances migration of smooth muscle cells, extravillous trophoblast cells and Chinese 
hamster ovary cells (Cavaillé et al., 2006; Chakraborty et al., 2002; Gockerman et al., 
1995; Jones et al., 1993). Recently Igfbp1 has been shown to activate kinases and 
small monomeric GTPases to affect cell migratory behavior of oligodendrocytes (Chesik 
et al., 2010). It may be possible that Igfbp1 has IGF-independent effects during 
pancreas development, involving the migration of precursor cells into defined anlagen. 
Finally, we identified two genes with novel expression patterns within the early 
pancreatic endoderm, Hapln3 and Syndecan-4. Hapln3 is an extracellular matrix protein 
that stabilizes hyaluronan matrix formation. Hyaluronan is shown to play roles cell-cell 
adhesion, migration, proliferation and differentiation (Comper and Laurent, 1978; 
Shimabukuro et al., 2005). Recently, Hapln3 has been shown to be necessary for 
cardiogenesis through its role in hyaluronan matrix formation around the developing 
heart in X. laevis (Ito et al., 2008). Has2, the catalytic enzyme which synthesizes 
hyaluronan, was shown to be expressed in the same cardiac region as Hapln3 (Ito et 
al., 2008), but was also increased in procine neonatal pancreas cells stimulated with 
EGF, where it was suggested it may play a role in the proliferation and migration of 
pancreatic duct cells (Jeon et al., 2004). It is possible that Hapln3 up-regulation in Ptf1a 
injected embryos may aid in hyaluronan matrix formation of the ectopic hyaluronan 
synthesized by Has2 leading to proliferation of Ptf1a cells resulting in ectopic pancreas.  
 
Our results are the first to show expression of halpn3 and syndecan-4 at such an early 
stage in the developing anterior ventral endoderm. To our knowledge, this is also the 
first time that hey1, syntaxin 1B, hapln3 and igfbp1 have been shown to be ectopically 
expressed in the developing endoderm in response to ptf1a mRNA over-expression in 
vivo. The fact that we found all of these genes to be upregulated only in the ventral 
endoderm at the level of the developing ventral pancreatic buds suggests that Ptf1a 
function is more pronounced in this region of the endoderm than in more central, dorsal 
or posterior areas. The fact that zebrafish ptf1a 
 
In conclusion, we are the first to report results from a microarray analysis of Ptf1a. We 
have found that Ptf1a modulates the expression of genes with a range of functions, from 
transcription to cell adhesion. Ptf1a is a key transcription factor necessary for pancreas 
development, and genes identified through this microarray are likely to play critical roles 
downstream of Ptf1a in defining cells along a particular pancreatic lineage. 
 
Methods 
Microarray analysis 
All mRNA for microinjection was created using the Ambion mMessage mMachine kit. To 
confirm targeting, experimental mRNAs were injected along with 400pg gfp mRNA and 
targeting verified by observing appropriate fluorescence. For functional analysis we 
selected only samples for which the entire anterior endoderm was targeted. 800 pg 
ptf1a and gfp mRNAs were injected into the dorsal vegetal blastomeres at the eight-cell 
stage. Anterior endoderm explants were collected at NF32 and NF36. RNA extraction of 
the sample sets (15 explants/set) was performed using TRIzol (Invitrogen) and purified 
using the RNeasy Micro Kit (Qiagen). RNA analysis, cDNA preparation and 
hybridization were performed by Genome Québec (McGill University, Montréal). 
Microarray results were analyzed using Affymetrix Expression Console and normalized 
using the Probe Logarithmic Intensity ERror estimation (PLIER) algorithm. Differential 
gene expression was analyzed using consecutive sampling with bin size of 25 (Guilbault 
et al., 2006; Novak et al., 2006a; Novak et al., 2006b; Novak et al., 2002). 
Representative standard deviations in each bin were calculated using non-linear 
regression to determine the boundaries of probability intervals. Candidate genes were 
selected as genes that lay beyond the probability interval of 0.9. The microarray data 
discussed in this publication have been deposited in NCBI's Gene Expression Omnibus 
(Edgar et al., 2002) and are accessible through GEO series accession number 
GSE34193. 
RT-PCR  
RT-PCR was performed on isolated anterior endoderm explants from ptf1a expressing 
and nonexpressing embryos and normalized to EF1-α. PCR conditions using Taq DNA 
polymerase (Invitrogen) included 1 min at 94°C preincubation, followed by 26, 28 or 30 
amplification cycles (except Ef1-α which only had 20, 22 or 24 cycles) comprising 94°C 
for 1 min, 55°C for 1 min, and 72°C for 1 min, and one cycle at 72°C for 10 min. The 
following primers were used: 
Stxbp1 Fwd 5’-TCTGCATCGGGTATCCGTTTCCTT-3’ and  
Stxbp1 Rev 5’-ATAAAGGTCGGGAGTGGTCGTTGT-3’ 
TA-2 Fwd 5’-ACAGTTATACCCAGCACAGCCCTT-3’ and 
TA-2 Rev 5’-ACTGAACCACAGAGCTGACACAGT-3’ 
Crbp2 Fwd 5’-CCGTGGGCGTTGAATTCGATGAAA-3’ and 
Crbp2 Fwd 5’-TTCCAGCCACGGTTGTTCTTCTCT-3’ 
C25H Fwd 5’-ACCTTTGCACTGGCCACTCAGTAT-3’ and 
C25H Fwd 5’-AAATGGTACCAGCTTGTGGGAGGA-3’ 
Igfbp1 Fwd 5’-TTACGGCCTAGTGAAGCAGCAGAT-3’ and 
Igfbp1 Rev 5’-TTCTGCGCTCAAGCATCTTTCGTG-3’ 
Irf1 Fwd 5’- GCACAGGCCCTTAATGTGATCCAA-3’ and 
Irf1 Rev 5’- GCAAACGAGTGGCAAACTGGTC-3’ 
Hapln3 Fwd 5’- GATGGCTGGTTGAGACTCATGTCT-3’ and 
Hapln3 Rev 5’- AGAAAGCTCACTCACAAGGGACG-3’ 
Hey1 Fwd 5’- CAGTAAAGCTGTGCATGGAAGGG-3’ and 
Hey1 Rev 5’- GTTGTATAGTCCGGGTTCATGTGC-3’ 
Sestrin1 Fwd 5’- CCTCCCCCGGATATAGATGT-3’ and 
Sestrin1 Rev 5’- CCTGCACTCGAAAAGTAGGC-3’ 
Syndecan-4 Fwd 5’- GCTAAGCCCAAAACATTGGA-3’ and 
Syndecan-4 Rev 5’- AAGGAAACTGCAACGACCAG-3’ 
 
Probes and whole mount in situ hybridizations 
All genes were cloned using cDNA from wild-type NF35 embryos with the following 
primers:  
Hapln3 Fwd 5’-GACCCAATTGTTTTGGGGCTACCT-3’ and Hapln3 Rev 5’-
GGGAGCGCAGTGAGTGCAGG-3’ designed based on BC046259. Hey1 Fwd 5’-
TCCTCCGCTGCTCTCCTCCA-3’ and Hey1 Rev 5’-GGGTGATGTCGCACCCAAGCA-
3’ designed based on BC084410. Igfbp1 Fwd 5’-CTGGATCCCCTGAAAACAGA-3’ and 
Igfbp1 Rev 5’-GGACCTGGGATTTTCTGGAT-3’ designed based on BC060008. Irf1 
Fwd 5’-TGCCATTGCCTGACAGCACA-3’ and Irf1 Rev 5’-
GGGCCTGTGCAAACCGATGC-3’ designed based on BC059984. Syndecan-4 Fwd 5’-
TCCTGCTGCTTTTAGCGCTGGTT-3’ and Syndecan-4 Rev 5’-
ACCAGGCCAACCAACGTGCC-3’ designed based on DQ116029. Syntaxin 1B Fwd 5’-
CAGAGCATCTCTGAGCATCT-3’ and Syntaxin 1B Rev 5’-
GATTCTTTCAGAGTCCCAGG-3’ designed based on BC084156. Syntaxin binding 
protein 1 ordered from XDB (http://xenopus.nibb.ac.jp/) contig number xl103a06. PCR 
products were cloned into pCRII (Invitrogen) and confirmed by sequencing. Whole 
mount in situ hybridizations were performed as described using BM purple (Horb et al., 
2003). 
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Figure Legends 
Figure 1. Microarray experiment schematic and ISH verification. a: Schematic diagram 
of microarray experiment. Eight-cell stage embryos were injected with either 800 pg of 
Ptf1a mRNA or 400 pg of GFP mRNA. Samples were collected at NF32 and NF36, 
RNA was extracted and hybridized to Affymetrix Xenopus laevis GeneChip 2.0 and 
Affymetrix Xenopus laevis GeneChip 1.0, respectively. b: NeuroD expression in gfp-
injected control embryos at NF32, punctate expression in the dorsal endoderm (black 
arrow). c: NeuroD expression in Ptf1a-injected embryos at NF32, increased expression 
in the dorsal endoderm (red arrows). de, dorsal endoderm. 
Figure 2. RT-PCR verification of selected differentially expressed genes from the 
microarray analyses. GFP and Ptf1a sample data provided from three different cycle 
timepoints. GFP, gfp mRNA-injected control; Ptf1a, ptf1a mRNA-injected; -RT, control 
reaction without reverse transcriptase. 
Figure 3. Expression pattern of transcription factors Hey1 and Irf1 in the developing 
endoderm. a: Transverse section through anterior endoderm at NF32 showing 
expression of hey1 restricted to the outer periphery of the endoderm. b: Expression of 
hey1 is more diffuse within the endoderm of the NF36 embryo, transverse section. c: 
NF44 whole gut showing expression of hey1 throughout the stomach, liver and 
pancreas. d: Transverse section through anterior endoderm at NF32 showing 
expression of irf1 throughout the entire endoderm. e: Transverse section at NF36 
shows restricted expression of irf1 along the dorsolateral endoderm. f: NF44 whole gut 
showing expression of irf1 throughout the stomach, liver, pancreas and in the intestine. 
dle, dorsolateral endoderm; ve, ventral endoderm; e, endoderm; l, liver; st, stomach; p, 
pancreas. 
Figure 4. Expression of SNARE complex proteins in the developing endoderm. a: 
Stxbp1 expressed along the dorsal mesendoderm periphery in the transverse section at 
NF32. b: Transverse section at NF36 shows punctate expression of stxbp1 restricted to 
the dorsal endoderm. c: Whole gut at NF44, stxbp1 has a punctate expression 
throughout the gut. d: NF42 liver and pancreas showing stxbp1 punctate expression in 
the dorsal pancreas and more diffuse expression in the liver. e: syntaxin 1B has minimal 
punctate expression within the endoderm at NF32. f: At NF36 there is an increase in the 
punctate expression of syntaxin 1B in the endoderm, transverse section. g: NF44 whole 
gut showing expression of syntaxin 1B in the stomach, liver and duodenum. h: NF42 
liver and pancreas with expression throughout the liver and pancreas. dme, dorsal 
mesendoderm; de, dorsal endoderm; l, liver; st, stomach; p, pancreas; dp, dorsal 
pancreas; vp, ventral pancreas. 
 
Figure 5. Expression of cell shape/adhesion genes in the developing endoderm. a: 
Transverse section through anterior endoderm at NF32 showing expression of igfbp1 
restricted to the dorsal and ventral endoderm. b: At NF36 igfbp1 is expressed most 
highly in the dorsal and ventral endoderm, but diffusely throughout the rest of the 
endoderm, transverse section. c: NF45 whole gut showing igfbp1 strongly expressed in 
the liver, and lighter in the duodenum. d: Hapln3 is expressed in the ventral endoderm 
in the transverse section at NF32. e: Transverse section at NF36, hapln3 expression is 
lost in the ventral endoderm, but is punctate through the endoderm. f: NF45 whole gut 
showing strong expression of hapln3 in the gall bladder, and punctate expression 
through the pancreas and duodenum g: Syndecan-4 is only expressed in the most 
ventral region of the endoderm shown in the transverse section of NF32. h: Transverse 
section at NF36 is showing expression of syndecan-4 only in the most ventral part of the 
endoderm, but stronger than at NF32. i: NF44 whole gut shows expression of 
syndecan-4 in the stomach and liver, and slightly in the pancreas. de, dorsal endoderm; 
ve, ventral endoderm; l, liver; st, stomach; p, pancreas. 
Figure 6.  Ptf1a overexpression promotes ectopic expression of candidate genes in the 
developing endoderm. All images are transverse section through the anterior endoderm. 
a,b: Stronger expression and expanded domain of hey1 in the anterior endoderm of a 
ptf1a mRNA injected embryo at NF32 (7/10 c,d: At NF36, expression of hey1 is 
stronger along the periphery of the endoderm (8/11). e,f: At NF32, syntaxin 1B  
expression is stronger in the dorsal endoderm and expands ectopically towards the 
ventral endoderm (7/10). g,h: Expression of syntaxin 1B is much stronger in the dorsal 
and ventral endoderm of ptf1a-injected embryos at NF36 (6/10). i,j: igfbp1 expression is 
expanded in the ventral endoderm but unchanged in the dorsal endoderm of ptf1a-
injected embryos at NF32 (9/9). k,l: At NF36 ptf1a-injected embryos the punctate 
expression of igfbp1 is stronger and more abundant (8/11). m,n: Expression domain of 
halpn3 in the ventral endoderm is stronger and broader in ptf1a-injected embryos at 
NF32 (6/10). o,p: At NF36, expression of hapln3 is ectopically expressed in the ventral 
endoderm but unaffected in the dorsal endoderm (5/10). de, dorsal endoderm; ve, 
ventral endoderm. 
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 Table 1.  Genes up-regulated Ptf1a microarray at NF32 and NF36. Genes found upregulated 
in both MA32 and MA36 relative to control samples. Genes are listed in descending order based 
on relative values in MA32. Unigene ID numbers that did not represent a known gene and 
duplicated genes were removed from this table. p < 0.05. 
  Fold Change 
Gene Title Unigene ID MA32 MA36 
Matrix metalloproteinase 1 Xl.26520 5.98 10.39 
Pancreas-specific transcription factor 1a Xl.29862 5.81 7.74 
Immunoresponsive gene 1 Xl.53505 5.70 10.06 
Interleukin-1-beta Xl.415 5.58 9.37 
Peripherin Xl.16232 5.51 5.26 
Transmembrane protein TA-2-like Xl.736 5.50 9.44 
Apolipoprotein O-like Xl.24724 5.30 4.97 
ELAV-like protein 4 Xl.1036 5.27 4.22 
Soluble toll-like receptor 5 Xl.53947 5.23 8.52 
Cholesterol 25-hydroxylase Xl.18444 5.13 8.40 
Matrix metalloproteinase 18 Xl.17465 4.98 9.10 
Fast skeletal troponin C beta Xl.24572 4.94 4.74 
Stathmin-like 2 Xl.11 4.90 5.08 
Troponin T type 3 (skeletal, fast) Xl.3362 4.89 4.96 
Dihydropyrimidinase-like 3 Xl.5161 4.76 3.03 
Similar to Parvalbumin (calcium binding protein) Xl.9653 4.41 4.13 
Olfactomedin 4 Xl.17389 4.40 4.86 
Tumor necrosis factor, alpha-induced protein 3 Xl.1952 4.40 6.15 
Neuronal pentraxin I XlAffx.54 4.37 5.99 
Oncomodulin Xl.48817 4.31 5.77 
Synaptotagmin 4 Xl.34868 4.06 2.95 
Tumor necrosis factor receptor superfamily, member 12A Xl.34690 3.96 4.82 
Carboxypeptidase A1 Xl.73839 3.96 3.85 
Jun B proto-oncogene Xl.52744 3.96 5.46 
Actinin, alpha 3 Xl.76514 3.95 3.11 
TNFAIP3 interacting protein 2 Xl.47119 3.84 6.47 
Amphiphysin Xl.14350 3.82 2.87 
Platelet-activating factor receptor Xl.4290 3.81 6.27 
Early growth response protein 1-A Xl.637 3.79 5.44 
Internexin neuronal intermediate filament protein, alpha Xl.13474 3.74 3.41 
Syntaxin 1B Xl.49106 3.69 3.29 
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 Xl.78163 3.58 6.09 
Phosphoglycerate mutase 2 Xl.12227 3.55 4.81 
Proto-oncogene c-Fos Xl.10283 3.48 4.39 
Interferon regulatory factor 1 Xl.1419 3.45 7.13 
Suppressor of cytokine signaling 3 Xl.26512 3.45 5.73 
Tumor necrosis factor receptor superfamily, member 11b Xl.47506 3.44 4.37 
Pleiotrophin Xl.900 3.34 4.41 
Early B-cell factor 2 Xl.547 3.19 4.15 
Olfactomedin 1 Xl.8515 3.16 2.40 
Matrix metalloproteinase 9 Xl.25126 3.13 4.96 
Mab-21-like 1 Xl.29719 3.13 2.58 
NUAK family, SNF1-like kinase, 2 Xl.8315 3.03 3.12 
Growth arrest and DNA-damage-inducible, gamma Xl.12125 2.98 4.01 
TRAF interacting protein TANK Xl.53193 2.98 3.47 
Pleckstrin homology-like domain family A member 2 Xl.57018 2.82 2.89 
Hes5.2-a Xl.586 2.76 3.06 
Thrombospondin 3 Xl.198 2.61 4.37 
Keratin Xl.76286 2.61 5.84 
Hyaluronan and proteoglycan link protein 3 (Hapln3) Xl.22996 2.52 5.35 
TRAF-interacting protein with FHA domain-containing 
protein A Xl.49742 2.51 3.57 
TNFAIP3 interacting protein 1 Xl.15972 2.48 3.73 
Sox3 Xl.22 2.48 2.59 
Claudin 5 Xl.14214 2.47 4.47 
Rho-related GTP-binding protein Rho6 precursor Xl.7206 2.43 4.11 
Hairy/enhancer-of-split related with YRPW motif 1 (Hey1) Xl.469 2.43 4.68 
Adenosine deaminase Xl.80690 2.42 4.65 
Tribbles homolog 1 Xl.75411 2.41 3.26 
B-cell translocation gene 5 Xl.51810 2.20 3.96 
Serpine1 Xl.25094 2.18 3.80 
B-cell translocation protein 2 Xl.48530 2.13 3.57 
FXYD domain containing ion transport regulator 6 Xl.18084 2.12 3.43 
Bone morphogenetic protein 2 A Xl.1138 2.04 3.18 
ATPase, Na+/K+ transporting, alpha 2 polypeptide Xl.10662 2.03 3.98 
 
 
Table 2.  Genes up-regulated in Ptf1a microarray at NF32. 
Genes have been sorted based on their fold change in MA32 relative to control samples. Only 
those with greater than 2-fold upregulation are listed. Unigene ID numbers that did not represent 
a known gene and duplicated genes were removed from this table. p < 0.05. 
 
Gene Title Unigene ID Fold Change 
Matrix metallopeptidase 8 Xl.49512 5.21 
Fatty acid binding protein 7, brain Xl.48742 5.00 
Thrombospondin 4 Xl.9871 4.92 
Tubulin, beta 3 Xl.57483 4.75 
Similar to oncomodulin Xl.3153 4.70 
Fast troponin I Xl.2142 4.62 
Myosin light chain, phosphorylatable, fast skeletal muscle Xl.6263 4.60 
Oncomodulin Xl.14726 4.48 
Calcium ATPase at 60A Xl.11405 4.46 
Fast skeletal troponin C beta Xl.1032 4.34 
SNAP25a Xl.8686 4.32 
Slow troponin I Xl.11074 4.30 
Neuritin 1-A Xl.11951 4.04 
Low molecular weight neuronal intermediate filament Xl.992 3.99 
Alpha-actinin-2 Xl.34825 3.95 
Growth associated protein 43 Xl.9994 3.90 
Similar to Parvalbumin (calcium binding protein) Xl.25492 3.87 
Neuritin-B precursor Xl.34198 3.85 
Neuro-oncological ventral antigen 1 Xl.47571 3.81 
Solute carrier family 1 Xl.20736 3.80 
Troponin I type 2 (skeletal, fast) Xl.18396 3.78 
Myosin binding protein H Xl.6142 3.77 
Guanine nucleotide binding protein (G protein), gamma 3 Xl.24553 3.67 
Tropomyosin 2 a isoform 1 Xl.21893 3.58 
Solute carrier family 1 Xl.20736 3.58 
Muscle-related coiled-coil protein Xl.57797 3.50 
Phosphoglycerate mutase 2 Xl.84002 3.36 
Enolase 1 alpha Xl.66912 3.34 
Calcium-dependent secretion activator 1 Xl.26179 3.34 
Growth associated protein 43 Xl.1133 3.33 
Enolase 3, beta muscle Xl.19056 3.32 
Beta-synuclein Xl.14705 3.26 
Sox10 Xl.1588 3.24 
Actin, alpha skeletal muscle Xl.70068 3.22 
Synuclein, gamma (breast cancer-specific protein 1) Xl.11348 3.22 
Middle molecular weight neurofilament protein NF-M(1) Xl.173 3.19 
Aspartyl beta-hydroxylase Xl.23399 3.10 
RUN and FYVE domain containing 3 Xl.8516 3.01 
Acetylcholine receptor subunit alpha-1-A Xl.1118 3.00 
Desmin Xl.2665 2.99 
Syntaxin binding protein 1 Xl.26111 2.96 
Jun oncogene Xl.541 2.93 
Dihydropyrimidinase-like 4 Xl.77348 2.90 
Jun proto-oncogene Xl.542 2.90 
Similar to calsequestrin 2 (cardiac muscle) Xl.15700 2.87 
Protein tweety homolog 1-A Xl.11254 2.85 
Collapsin response mediator protein 1 Xl.50837 2.83 
Chondromodulin-I precursor Xl.21971 2.79 
Synaptophysin Xl.230 2.79 
Transcription factor Sp8 Xl.49163 2.77 
Neural cell adhesion molecule L1 Xl.21565 2.76 
Tubulin Xl.8919 2.76 
Protocadherin 8 Xl.72042 2.75 
CUGBP Elav-like family member 3-B Xl.12160 2.73 
CUGBP Elav-like family member 3-A Xl.986 2.73 
Pax6 Xl.647 2.69 
Synaptophysin Xl.232 2.66 
Dihydropyrimidinase-like 2 Xl.3001 2.65 
Kinesin family member 5A Xl.18417 2.64 
Middle molecular weight neurofilament protein NF-M(2) Xl.174 2.61 
VENT homeobox 1 Xl.1420 2.57 
MICAL-like 2 Xl.34034 2.56 
Synaptotagmin 4 Xl.48319 2.55 
Neuritin 1-A Xl.11951 2.53 
Tubulin beta-2 chain Xl.121 2.50 
Diacylglycerol kinase iota Xl.16337 2.49 
Carboxypeptidase E Xl.8483 2.46 
Cell adhesion molecule 3 precursor Xl.23549 2.45 
Neuronal pentraxin-2 precursor Xl.11864 2.45 
Reticulon-1-B Xl.8555 2.45 
Actin, alpha skeletal muscle 3 Xl.24656 2.43 
Lysyl oxidase homolog 3 precursor Xl.13606 2.42 
Similar to myozenin 1 Xl.21921 2.41 
Trimeric intracellular cation channel type A Xl.45053 2.39 
Seizure protein 6 homolog precursor Xl.51942 2.36 
Guanine nucleotide-binding protein G(O) alpha subunit 1 Xl.20976 2.36 
Fox-1 homolog C Xl.57891 2.35 
Coiled-coil domain containing 28B Xl.9739 2.35 
Zinc finger protein ZIC 1 Xl.1796 2.33 
RAB33A, member RAS oncogene family Xl.47462 2.33 
Enah/Vasp-like Xl.12544 2.32 
Wnt-8 Xl.49 2.29 
Stathmin-like 3 Xl.21810 2.29 
Hes-4-A Xl.25977 2.20 
Sodium/potassium-transporting ATPase subunit beta-1-
interacting protein 4 Xl.55497 2.20 
Zinc finger protein 36, C3H type, homolog Xl.24023 2.17 
Calcium channel, voltage-dependent, beta 3 subunit Xl.53876 2.09 
Hes5.1 Xl.48575 2.03 
 
Table 3.  Genes up-regulated in Ptf1a microarray at NF36.  
Genes have been sorted based on their fold change in MA36 relative to control samples. Only 
those with greater than 4-fold upregulation are listed. Unigene ID numbers that did not represent 
a known gene and duplicated genes were removed from this table. p < 0.05. 
 
Gene Title Unigene ID Fold Change 
Phosphoenolpyruvate carboxykinase 1, cytosolic Xl.12459 8.92 
Glucose-6-phosphatase, catalytic Xl.12866 7.44 
Ornithine decarboxylase-2 Xl.8949 7.23 
Phosphoenolpyruvate carboxykinase 1 (soluble) Xl.18730 7.03 
Similar to glucose-6-phosphatase Xl.5165 6.95 
Uroplakin III Xl.25311 6.65 
Insulin-like growth factor binding protein 1 Xl.34669 6.61 
Na+/K+ -ATPase beta 2 subunit Xl.53667 6.57 
Hydrogen/potassium-exchanging ATPase 12A b Xl.2659 6.46 
Uncoupling protein 3 (mitochondrial, proton carrier) Xl.49433 6.46 
Arginase, non-hepatic 1 Xl.892 6.43 
Carboxypeptidase B1 Xl.26001 6.38 
Similar to deoxyribonuclease I-like 3 Xl.6017 6.26 
CCAAT-enhancer binding protein delta Xl.29876 6.24 
Serine/threonine-protein kinase Sgk1-A Xl.7842 6.22 
Anterior gradient 2 Xl.25847 6.21 
Paired box protein Pax-9 Xl.21602 6.06 
Uroplakin 1B Xl.8143 5.93 
Tripartite motif-containing 29 Xl.9051 5.85 
Keratin, type I cytoskeletal 47 kDa Xl.66586 5.82 
Cornifelin homolog B Xl.23712 5.82 
Matrix metalloproteinase 13 Xl.9058 5.73 
Caveolin-3 Xl.53974 5.69 
Peroxisomal membrane protein 2, 22kDa Xl.83319 5.66 
Pyruvate dehydrogenase kinase 2 Xl.1717 5.55 
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 Xl.15867 5.54 
Claudin 4 Xl.53796 5.54 
Purine nucleoside phosphorylase Xl.57569 5.53 
Arrestin domain containing 2 Xl.19508 5.52 
Otogelin Xl.847 5.50 
V-type proton ATPase subunit G 3 Xl.34612 5.43 
Serpin peptidase inhibitor, clade E, member 2 Xl.12045 5.31 
Glutathione S-transferase P 1 Xl.54920 5.27 
L-lactate dehydrogenase C chain Xl.4591 5.25 
Glucose-6-phosphatase, catalytic, 2 Xl.47697 5.21 
Guanylyl cyclase-1 Xl.906 5.17 
Prostaglandin-endoperoxide synthase  Xl.78035 5.09 
Serine dehydratase Xl.72557 5.05 
Phospholipid scramblase 1 Xl.60828 5.04 
Neurogenic differentiation 1(NeuroD) Xl.26304 5.02 
Carbonic anhydrase XII Xl.10362 4.97 
Amiloride-sensitive sodium channel subunit beta-2 Xl.1175 4.97 
Keratin 15 Xl.57085 4.97 
UDP-GlcNAc:betaGal beta-1,3-N-
acetylglucosaminyltransferase 7 Xl.8104 4.95 
Claudin 1 Xl.16310 4.94 
Sox9 Xl.1690 4.92 
Tetraspanin 1 Xl.39094 4.92 
X-epilectin Xl.6048 4.91 
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 Xl.8939 4.88 
Sciellen Xl.15658 4.88 
Calpain 9 Xl.47406 4.87 
Pendrin-like anion exchanger Xl.10887 4.78 
Lectin, galactoside-binding, soluble, 3 Xl.1779 4.76 
Collagen, type II, alpha 1 (col2a1) Xl.606 4.74 
ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A, 
isoform 1 Xl.54891 4.72 
Collagen, type I, alpha 1 Xl.47042 4.65 
Collagen, type I, alpha 2 Xl.49126 4.65 
Sestrin-1 Xl.12255 4.58 
Collagen, type II, alpha 1 (col2a1) Xl.606 4.57 
Alkaline phosphatase Xl.1299 4.57 
Collagen, type VI, alpha 1 (col6a1) Xl.9863 4.55 
Cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kDa, b Xl.24776 4.53 
T-box transcription factor TBX1 Xl.51448 4.50 
Forkhead box protein E1 Xl.50069 4.48 
Versican Xl.70991 4.46 
Villin-like Xl.15156 4.45 
Osteoglycin Xl.21905 4.45 
Synaptotagmin-like 2 Xl.52466 4.38 
Fibroblast growth factor binding protein 1 Xl.48872 4.38 
Augurin precursor Xl.21897 4.37 
ATPase, H+ transporting, lysosomal V0 subunit a4 Xl.2715 4.34 
Somatostatin Xl.13593 4.33 
NIPA-like domain containing 4 Xl.5679 4.31 
Actin, alpha 2, smooth muscle, aorta (acta2) Xl.83891 4.30 
Phosphoinositide-3-kinase interacting protein 1 Xl.77369 4.30 
Distal-less homeobox 3 (dlx3-a) Xl.838 4.30 
Transcription factor AP-2 alpha (tfap2a-a) Xl.2143 4.28 
Glutamate-ammonia ligase (glutamine synthase) (glul) Xl.47079 4.25 
GDP-mannose 4, 6-dehydratase Xl.10260 4.23 
Calpain 1, (mu/I) large subunit Xl.3776 4.23 
D-dopachrome decarboxylase-A Xl.23562 4.23 
Adenylate kinase 1 Xl.25877 4.22 
5-hydroxytryptamine (serotonin) receptor 3A Xl.9068 4.22 
Myosin, heavy chain 6, cardiac muscle, alpha Xl.3161 4.22 
Arrestin domain containing 3 Xl.25985 4.19 
Annexin A1 Xl.2308 4.18 
Macrophage stimulating 1 receptor (c-met-related tyrosine 
kinase) Xl.115 4.18 
Keratin 16 Xl.15435 4.15 
Sal-like 4 (sall4) Xl.77515 4.15 
Zinc finger protein 36, C3H type, homolog Xl.26472 4.10 
Distal-less homeobox 5 (dlx-5) Xl.18401 4.09 
Histidine ammonia-lyase Xl.2256 4.08 
Fucosyltransferase 6 (alpha (1,3) fucosyltransferase) Xl.16504 4.07 
Aquaporin-3 Xl.34454 4.07 
Phosphatidylinositol glycan anchor biosynthesis (PIG-S) Xl.48652 4.05 
Aquaporin 1 Xl.5043 4.04 
Myosin, light chain 4, alkali; atrial, embryonic Xl.11969 4.03 
Plasminogen activator, tissue Xl.14787 4.02 
Coagulation factor II (thrombin) receptor-like 2 Xl.23535 4.01 
 
 
Table 4.  Overlapping genes up-regulated in both Ngn3 and Ptf1a microarrays. Genes have 
been sorted based on their fold change in the Ngn3 microarray. p < 0.05. 
 
  Fold Change 
Gene Title Unigene ID Ngn3 MA32 MA36 
Carboxypeptidase E Xl.17761 2.59 2.51 2.84 
Pyruvate dehydrogenase kinase, isoenzyme 2 Xl.1717 2.42   5.55 
Xenopus atonal homolog-3 Xl.1263 2.12   2.22 
Prostaglandin-endoperoxide synthase 2 Xl.33329 2.11   5.09 
Hypothetical protein MGC68579 Xl.34749 2.08   4.36 
Elavl3 Xl.1035 1.84   2.38 
Zinc finger, AN1-type domain 2A Xl.48357 1.82   3.04 
Stathmin-like 3 Xl.21810 1.81 2.29  
Esr10 Xl.9271 1.8   2.68 
Hes-5.1 Xl.48575 1.75 2.03  
Phosphoinositide-3-kinase interacting protein 1 Xl.49469 1.73   4.30 
Hey1 Xl.469 1.69 2.43 4.68 
Growth arrest and DNA-damage-inducible, gamma Xl.12125 1.69 2.98 4.01 
Similar to enhancer of split related Xl.8440 1.68 2.20 3.35 
VENT homeobox 1, gene 1 Xl.1420 1.51 2.57  
 
 
